MNO-863

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameMNO-863
Drug Alias NameMNO-863
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsNeuropeptide Y receptors agonists
TargetsGlucagon-like peptide 1 receptorNeuropeptide Y receptors
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMoon (Guangzhou) Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesMoon (Guangzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A